Citadel Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.58B | Sell |
1,721,100
-515,300
| -23% | -$522M | 0.26% | 55 |
|
|
2025
Q4 | $2.4B | Sell |
2,236,400
-90,800
| -4% | -$86.8M | 0.36% | 40 |
|
|
2025
Q3 | $1.78B | Sell |
2,327,200
-1,412,300
| -38% | -$1.05B | 0.27% | 48 |
|
|
2025
Q2 | $2.92B | Buy |
3,739,500
+1,803,800
| +93% | +$1.4B | 0.51% | 27 |
|
|
2025
Q1 | $1.6B | Sell |
1,935,700
-212,100
| -10% | -$176M | 0.3% | 35 |
|
|
2024
Q4 | $1.66B | Buy |
2,147,800
+324,200
| +18% | +$268M | 0.29% | 35 |
|
|
2024
Q3 | $1.62B | Buy |
1,823,600
+517,500
| +40% | +$465M | 0.31% | 33 |
|
|
2024
Q2 | $1.18B | Sell |
1,306,100
-422,600
| -24% | -$338M | 0.24% | 46 |
|
|
2024
Q1 | $1.34B | Buy |
1,728,700
+415,700
| +32% | +$296M | 0.26% | 38 |
|
|
2023
Q4 | $765M | Buy |
1,313,000
+166,700
| +15% | +$97.3M | 0.15% | 65 |
|
|
2023
Q3 | $616M | Sell |
1,146,300
-119,500
| -9% | -$61.6M | 0.13% | 75 |
|
|
2023
Q2 | $594M | Buy |
1,265,800
+265,900
| +27% | +$112M | 0.12% | 81 |
|
|
2023
Q1 | $343M | Sell |
999,900
-75,000
| -7% | -$25.3M | 0.08% | 166 |
|
|
2022
Q4 | $393M | Sell |
1,074,900
-395,100
| -27% | -$140M | 0.09% | 152 |
|
|
2022
Q3 | $475M | Buy |
1,470,000
+955,700
| +186% | +$303M | 0.11% | 100 |
|
|
2022
Q2 | $167M | Sell |
514,300
-264,400
| -34% | -$79.4M | 0.04% | 347 |
|
|
2022
Q1 | $223M | Sell |
778,700
-192,700
| -20% | -$49.6M | 0.05% | 303 |
|
|
2021
Q4 | $268M | Sell |
971,400
-204,100
| -17% | -$51.7M | 0.05% | 251 |
|
|
2021
Q3 | $272M | Buy |
1,175,500
+319,800
| +37% | +$78.9M | 0.06% | 244 |
|
|
2021
Q2 | $196M | Sell |
855,700
-51,400
| -6% | -$10.3M | 0.04% | 322 |
|
|
2021
Q1 | $169M | Buy |
907,100
+79,200
| +10% | +$15.5M | 0.04% | 349 |
|
|
2020
Q4 | $140M | Buy |
827,900
+358,600
| +76% | +$53.5M | 0.04% | 393 |
|
|
2020
Q3 | $69.5M | Buy |
469,300
+8,800
| +2% | +$1.36M | 0.02% | 652 |
|
|
2020
Q2 | $75.6M | Sell |
460,500
-87,500
| -16% | -$13.4M | 0.03% | 542 |
|
|
2020
Q1 | $76M | Sell |
548,000
-121,100
| -18% | -$16.6M | 0.03% | 452 |
|
|
2019
Q4 | $87.9M | Buy |
669,100
+273,600
| +69% | +$31.7M | 0.04% | 461 |
|
|
2019
Q3 | $44.2M | Buy |
395,500
+70,400
| +22% | +$7.84M | 0.02% | 829 |
|
|
2019
Q2 | $36M | Sell |
325,100
-108,600
| -25% | -$12.8M | 0.02% | 941 |
|
|
2019
Q1 | $56.3M | Sell |
433,700
-166,300
| -28% | -$20.2M | 0.03% | 631 |
|
|
2018
Q4 | $69.4M | Sell |
600,000
-150,100
| -20% | -$16.8M | 0.04% | 470 |
|
|
2018
Q3 | $80.5M | Buy |
750,100
+394,700
| +111% | +$39.5M | 0.04% | 503 |
|
|
2018
Q2 | $30.3M | Buy |
355,400
+110,500
| +45% | +$9.08M | 0.01% | 985 |
|
|
2018
Q1 | $18.9M | Sell |
244,900
-251,700
| -51% | -$20.3M | 0.01% | 1164 |
|
|
2017
Q4 | $41.9M | Buy |
496,600
+270,900
| +120% | +$23M | 0.03% | 711 |
|
|
2017
Q3 | $19.3M | Sell |
225,700
-53,700
| -19% | -$4.4M | 0.01% | 1088 |
|
|
2017
Q2 | $23M | Sell |
279,400
-27,200
| -9% | -$2.22M | 0.02% | 912 |
|
|
2017
Q1 | $25.8M | Sell |
306,600
-214,800
| -41% | -$17.2M | 0.02% | 801 |
|
|
2016
Q4 | $38.3M | Buy |
521,400
+115,600
| +28% | +$8.61M | 0.04% | 499 |
|
|
2016
Q3 | $32.6M | Buy |
405,800
+103,500
| +34% | +$8.28M | 0.03% | 601 |
|
|
2016
Q2 | $23.8M | Buy |
302,300
+28,500
| +10% | +$2.15M | 0.03% | 659 |
|
|
2016
Q1 | $19.7M | Buy |
273,800
+75,100
| +38% | +$5.68M | 0.02% | 753 |
|
|
2015
Q4 | $16.7M | Sell |
198,700
-130,700
| -40% | -$10.8M | 0.02% | 940 |
|
|
2015
Q3 | $27.6M | Buy |
329,400
+27,500
| +9% | +$2.32M | 0.03% | 704 |
|
|
2015
Q2 | $25.2M | Buy |
301,900
+68,900
| +30% | +$5.25M | 0.02% | 857 |
|
|
2015
Q1 | $16.9M | Buy |
233,000
+99,900
| +75% | +$7.11M | 0.02% | 1079 |
|
|
2014
Q4 | $9.18M | Sell |
133,100
-700
| -0.5% | -$47.2K | 0.01% | 1459 |
|
|
2014
Q3 | $8.68M | Sell |
133,800
-11,600
| -8% | -$734K | 0.01% | 1476 |
|
|
2014
Q2 | $9.04M | Sell |
145,400
-45,000
| -24% | -$2.68M | 0.01% | 1352 |
|
|
2014
Q1 | $11.2M | Sell |
190,400
-24,800
| -12% | -$1.38M | 0.01% | 1187 |
|
|
2013
Q4 | $11M | Sell |
215,200
-35,300
| -14% | -$1.77M | 0.01% | 1154 |
|
|
2013
Q3 | $12.6M | Buy |
250,500
+15,400
| +7% | +$806K | 0.02% | 968 |
|
|
2013
Q2 | $11.5M | Buy |
+235,100
| New | +$12.8M | 0.02% | 979 |
|
Other funds holding LLY
VCM
VPM
Citadel Advisors's LLY Position: Q1 2026 in Review
Citadel Advisors reduced its Eli Lilly (LLY) stake by 65% in Q1 2026, selling an estimated $464M and leaving 241,714 shares worth $222M. The position accounts for 0.04% of the portfolio, ranked #410.
Citadel Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $880M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Citadel Advisors held 241,714 shares of Eli Lilly worth $222M as of Q1 2026.
- Citadel Advisors sold 458,045 Eli Lilly shares in Q1 2026, an estimated $464M.
- Eli Lilly made up 0.04% of Citadel Advisors's portfolio in Q1 2026, its #410 holding.
- Citadel Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's Eli Lilly position peaked at $880M in Q3 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.